Gary J. Nabel

National Institutes of Health — United States

Immunology and Microbiology · Life Sciences

133h-index59.5kcitations506works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(191), Immune Cell Function and Interaction(105), Virus-based gene therapy research(87), Immunotherapy and Immune Responses(62), Viral Infections and Outbreaks Research(55)

Publications504 total

MDX2003, a novel tetraspecific T cell engager-expander targeting CD19xCD20xCD3xCD28, demonstrates potent preclinical activity against B cell malignancies
Blood·2025
1156 MDX2004, a novel immune rejuvenator targeting CD3, CD28, and 4–1BB, augments tumor immunity in preclinical animal models
Regular and Young Investigator Award Abstracts·2025Open Access
A phase 1/2a, multicenter, first-in-human, open-label clinical trial evaluating MDX2001, a tetraspecific T cell engager-expander in patients with advanced solid tumors.
Journal of Clinical Oncology·2025· 1 cited
Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
Immunity·2025· 7 citedOpen Access
Direct gene transfer for the treatment of human disease
Garland Science eBooks·2024
1287 Preclinical characterization of MDX2001, a novel tetraspecific T cell engager (CD3/CD28) targeting TROP2 and c-MET in solid tumor malignancies
Regular and Young Investigator Award Abstracts·2024Open Access
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivo
Science Translational Medicine·2024· 2 cited
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Nature Communications·2023· 15 citedOpen Access
Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report
Annals of the New York Academy of Sciences·2023Open Access
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
Science Translational Medicine·2022· 39 cited
A trispecific Ab directed to HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Research Square (Research Square)·2022Open Access
A multispecific antibody prevents immune escape and confers pan-SARS-CoV-2 neutralization
2022· 5 citedOpen Access
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle
npj Vaccines·2022· 24 citedOpen Access
A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice
Science Translational Medicine·2022· 93 citedOpen Access
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
Nature Medicine·2022· 84 citedOpen Access
Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
Nature·2022· 12 citedOpen Access
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
Nature·2022· 145 cited
A bivalent EBV vaccine induces neutralizing antibodies that block B and epithelial cell infection and confer immunity in humanized mice
2022· 2 citedOpen Access
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys
Cell Reports·2022· 30 citedOpen Access
Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP Vaccine
2021· 12 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

John R. Mascola(18), Zhi-Yong Yang(12), Peter D. Kwong(12), Tongqing Zhou(7), Ling Xu(7), Srinivas S. Rao(7), Barton F. Haynes(7), Dennis R. Burton(7), David C. Montefiori(6), Xueling Wu(5), Sijy O’Dell(5), Richard T. Wyatt(5), Yongping Yang(5), Jiang Zhu(5), Joseph Sodroski(5), Zhiyong Yang(5), Wing-Pui Kong(5), Mattia Bonsignori(5), Elizabeth G. Nabel(5), Stephen D. Schmidt(4)